Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSXV/LSL stock hub

TSXV/LSL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSXV/LSLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

44.2M

TSX Venture Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSXV/LSL

In the news

Latest news · TSXV/LSL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E16.1

P25 7.4P50 15.6P75 34.3

ROE12.1

P25 -121.5P50 -40.9P75 0.5

ROIC2.9

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSXV/LSL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

157

Groups with data

Currency

CAD

Showing 157 of 157 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	186
Employees Change	83%
Employees Change Percent	81.37
Enterprise value	CAD 65.8M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	CAD 44.2M
Price	CAD 0.37
Price currency	CAD
Rev Per Employee	144,107.53x
Sector	Healthcare
Sic	2833
Symbol	tsxv/LSL
Website	https://www.groupelslpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.27%
EV Earnings	23.73x
EV/EBIT	46.54x
EV/EBITDA	16.42x
EV/Sales	2.46x
P/B ratio	1.74x
P/E ratio	16.09x
P/S ratio	1.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.28%
EBITDA Margin	14.18%
Gross margin	29.73%
Gross Profit	CAD 8M
Gross Profit Growth	100.45%
Gross Profit Growth Q	95.23%
Net Income	CAD 2.8M
Pretax Margin	10.54%
Profit Margin	10.35%
Profit Per Employee	CAD 14,919
ROA	1.8
ROCE	3.03
ROE	12.13
ROIC	2.94
Roic5y	-8.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.6%
Cagr3y	-12.77%
Revenue Growth	69.41x
Revenue Growth Q	88.98x
Revenue Growth3 Y	47.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.55
Assets	CAD 60.2M
Current Assets	CAD 20.7M
Current Liabilities	CAD 13.5M
Debt	CAD 21.6M
Debt EBITDA	CAD 5.39
Debt Equity	CAD 0.85
Equity	CAD 25.4M
Interest Coverage	0.53
Liabilities	CAD 34.8M
Long Term Assets	CAD 39.5M
Long Term Liabilities	CAD 21.3M
Net Cash	CAD -21.6M
Net Cash By Market Cap	CAD -48.83
Net Debt EBITDA	CAD 5.68
Net Debt Equity	CAD 0.85
Tangible Book Value	CAD 11.1M
Tangible Book Value Per Share	CAD 0.1
WACC	5.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Net Working Capital	CAD 13.5M
Working Capital	CAD 7.1M
Working Capital Turnover	CAD 6.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.59%
200-day SMA	0.4
3Y total return	-33.64%
50-day SMA	0.41
50-day SMA vs 200-day SMA	50over200
All Time High	1
All Time High Change	-63.5%
All Time High Date	2023-03-03
All Time Low	0.29
All Time Low Change	25.86%
All Time Low Date	2025-03-26
ATR	0.01
Beta	-0.47
Beta1y	0.42
Beta2y	0.64
Ch YTD	4.29
High	0.37
High52	0.56
High52 Date	2026-01-29
High52ch	-34.82%
Low	0.37
Low52	0.33
Low52 Date	2025-12-18
Low52ch	10.61%
Ma50ch	-9.94%
Price vs 200-day SMA	-9.45%
RSI	33.05
RSI Monthly	43.33
RSI Weekly	40.67
Sharpe ratio	0.28x
Sortino ratio	0.6
Total Return	-19.11%
Tr YTD	4.29
Tr1m	-5.19%
Tr1w	-10.98%
Tr3m	-29.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 1.4M
Operating Income Growth Q	358.1
Operating margin	5.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89,645,819%
Shares Insiders	26.05%
Shares Out	121,220,176
Shares Qo Q	0%
Shares Yo Y	19.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	94,414.7x
Bv Per Share	0.22
Ch1m	-5.19
Ch1w	-10.98
Ch1y	-7.59
Ch3m	-29.81
Ch3y	-33.64
Ch6m	-1.35
Change	-1.35%
Change From Open	-1.35
Close	0.37
Days Gap	0
Depreciation Amortization	2,386,000
Dollar Volume	19,345
Earnings Date	2026-02-27
EBIT	CAD 1.4M
EBITDA	CAD 3.8M
EPS	CAD 0.02
F Score	5
Fiscal Year End	December
Graham Number	0.33488
Graham Upside	-8.25
Income Tax	CAD 50,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-09-30
Ma150	0.41
Ma150ch	-9.88%
Ma20	0.4
Ma20ch	-9.32%
Open	0.37
Position In Range	0
Ppne	24,825,000
Price Date	2026-05-08
Price EBITDA	CAD 11.64
Ptbv Ratio	4
Relative Volume	0.56x
Revenue	26,804,000x
Tax By Revenue	0.19x
Tax Rate	1.77%
Tr6m	-1.35%
Volume	53,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSXV/LSL pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/LSL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSXV/LSL?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+26.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+19.1%

Negative means the company is buying back shares.

Technical

TSXV/LSL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.0

Neutral momentum band

Price vs 200-day MA

-9.5%

50/200-day relationship not available

Beta (5Y)

-0.47

Less volatile than the market

Sharpe ratio

0.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSXV/LSL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/LSL stock rating?

tsxv/LSL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/LSL analysis?

The full report lives at /stocks/tsxv/LSL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/LSL?

The latest report frames tsxv/LSL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/LSL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.